200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 20187-55-7

20187-55-7

20187-55-7 | Acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-

CAS No: 20187-55-7 Catalog No: AG0027WQ MDL No:MFCD00866158

Product Description

Catalog Number:
AG0027WQ
Chemical Name:
Acetic acid, 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-
CAS Number:
20187-55-7
Molecular Formula:
C16H14N2O3
Molecular Weight:
282.2940
MDL Number:
MFCD00866158
IUPAC Name:
2-(1-benzylindazol-3-yl)oxyacetic acid
InChI:
InChI=1S/C16H14N2O3/c19-15(20)11-21-16-13-8-4-5-9-14(13)18(17-16)10-12-6-2-1-3-7-12/h1-9H,10-11H2,(H,19,20)
InChI Key:
BYFMCKSPFYVMOU-UHFFFAOYSA-N
SMILES:
OC(=O)COc1nn(c2c1cccc2)Cc1ccccc1
EC Number:
243-569-2
UNII:
G4AG71204O

Properties

Complexity:
357  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
282.1g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
282.299g/mol
Monoisotopic Mass:
282.1g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
64.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.1  

Literature

Title Journal
Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models. Toxicology and applied pharmacology 20170301
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). PLoS computational biology 20111201
Synthesis and biological evaluations of novel bendazac lysine analogues as potent anticataract agents. Bioorganic & medicinal chemistry letters 20100401
Gene expression profiling in rat liver treated with compounds inducing elevation of bilirubin. Human & experimental toxicology 20090401
Advances in pharmacological strategies for the prevention of cataract development. Indian journal of ophthalmology 20090101
Topical ocular delivery of NSAIDs. The AAPS journal 20080601
Medical treatment of cataract. Clinical & experimental ophthalmology 20070101
Bendazac lysine inhibition of human lens epithelial cell adhesion to polymethylmethacrylate intraocular lenses. Ophthalmic research 20040101
Antidenaturant drugs for cataract and other condensation diseases. Medical hypotheses 20010101

© 2019 Angene International Limited. All rights Reserved.